TC
Insider selling
Thomas Catinazzo sold $228K of Relay Therapeutics, Inc. (RLAY) stock
Thomas Catinazzo, Chief Financial Officer of Relay Therapeutics, Inc. (RLAY), sold 17,717 shares of RLAY stock worth $228K, per an SEC Form 4 filed May 14, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade was reported on May 14, 2026.
RLAY has moved +42.3% since the trade date, from $12.78 to $18.19 (Sep 21, 2026 close).
- Traded
- May 14, 2026
- Disclosed
- May 14, 2026
- Filing delay
- 0 days
- Price since
- +42.3%
- Role
- Chief Financial Officer
- Source
- SEC Form 4
More RLAY insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.